Combining the informational content present in routine diagnostic data, including annotated CT scans, digitized immunohistochemistry slides, and common genomic alterations in NSCLC, can improve the prediction of responses to programmed cell death protein 1 or programmed cell death-ligand 1 blockade [40]. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.